Medika d.d. (ZSE:MDKA)
Croatia
· Delayed Price · Currency is HRK · Price in EUR 5,250.00
0.00 (0.00%)
At close: May 12, 2025
Medika d.d. Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 850.58 | 826.32 | 745.79 | 628.1 | 549.59 | 528.45 | Upgrade
|
| Other Revenue | 6.12 | 6.12 | 4.69 | - | - | - | Upgrade
|
| Revenue | 856.7 | 832.45 | 750.49 | 628.1 | 549.59 | 528.45 | Upgrade
|
| Revenue Growth (YoY) | 10.35% | 10.92% | 19.49% | 14.28% | 4.00% | 7.83% | Upgrade
|
| Cost of Revenue | 789.94 | 766.87 | 690.85 | 577.1 | 504.03 | 486.32 | Upgrade
|
| Gross Profit | 66.76 | 65.57 | 59.64 | 51 | 45.56 | 42.13 | Upgrade
|
| Selling, General & Admin | 26.68 | 26.21 | 22.93 | 20.62 | 19.18 | 17.16 | Upgrade
|
| Other Operating Expenses | 11.19 | 11.39 | 10.05 | 9.04 | 7.8 | 7.39 | Upgrade
|
| Operating Expenses | 42.76 | 42.38 | 37.31 | 33.69 | 30.87 | 28.1 | Upgrade
|
| Operating Income | 24 | 23.19 | 22.33 | 17.31 | 14.69 | 14.03 | Upgrade
|
| Interest Expense | -2.2 | -2 | -1.73 | -0.37 | -0.59 | -0.92 | Upgrade
|
| Interest & Investment Income | 2.89 | 3 | 2.28 | 2.65 | 1.4 | 0.23 | Upgrade
|
| Earnings From Equity Investments | 0.56 | 0.51 | 0.43 | 0.43 | 0.38 | 0.3 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.01 | -0.01 | -0.01 | -0.28 | 0.13 | -1.26 | Upgrade
|
| EBT Excluding Unusual Items | 25.25 | 24.69 | 23.3 | 19.74 | 16 | 12.39 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.14 | 0.14 | 1.08 | 0.9 | 0.08 | 0.03 | Upgrade
|
| Legal Settlements | - | - | - | - | - | -0 | Upgrade
|
| Pretax Income | 25.38 | 24.83 | 24.37 | 20.64 | 16.08 | 12.42 | Upgrade
|
| Income Tax Expense | 4.49 | 4.52 | 4.29 | 5.15 | 2.84 | 2.24 | Upgrade
|
| Net Income | 20.9 | 20.31 | 20.08 | 15.5 | 13.24 | 10.18 | Upgrade
|
| Net Income to Common | 20.9 | 20.31 | 20.08 | 15.5 | 13.24 | 10.18 | Upgrade
|
| Net Income Growth | 3.04% | 1.15% | 29.59% | 17.03% | 30.03% | 4.11% | Upgrade
|
| Shares Outstanding (Basic) | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | - | - | - | 2.56% | 3.59% | - | Upgrade
|
| EPS (Basic) | 721.72 | 701.49 | 693.51 | 535.16 | 468.99 | 373.62 | Upgrade
|
| EPS (Diluted) | 721.72 | 701.49 | 693.51 | 535.16 | 468.99 | 373.62 | Upgrade
|
| EPS Growth | 3.04% | 1.15% | 29.59% | 14.11% | 25.53% | 4.11% | Upgrade
|
| Free Cash Flow | -1.72 | -34.56 | 19.58 | 7.33 | 35.88 | 13.03 | Upgrade
|
| Free Cash Flow Per Share | -59.39 | -1193.44 | 676.38 | 253.26 | 1270.88 | 477.92 | Upgrade
|
| Dividend Per Share | - | - | 200.000 | 215.000 | 186.284 | 185.440 | Upgrade
|
| Dividend Growth | - | - | -6.98% | 15.42% | 0.46% | 4.54% | Upgrade
|
| Gross Margin | 7.79% | 7.88% | 7.95% | 8.12% | 8.29% | 7.97% | Upgrade
|
| Operating Margin | 2.80% | 2.79% | 2.98% | 2.76% | 2.67% | 2.66% | Upgrade
|
| Profit Margin | 2.44% | 2.44% | 2.68% | 2.47% | 2.41% | 1.93% | Upgrade
|
| Free Cash Flow Margin | -0.20% | -4.15% | 2.61% | 1.17% | 6.53% | 2.46% | Upgrade
|
| EBITDA | 26.17 | 25.26 | 24.09 | 19.36 | 16.62 | 15.8 | Upgrade
|
| EBITDA Margin | 3.06% | 3.03% | 3.21% | 3.08% | 3.02% | 2.99% | Upgrade
|
| D&A For EBITDA | 2.17 | 2.07 | 1.75 | 2.05 | 1.93 | 1.77 | Upgrade
|
| EBIT | 24 | 23.19 | 22.33 | 17.31 | 14.69 | 14.03 | Upgrade
|
| EBIT Margin | 2.80% | 2.79% | 2.98% | 2.76% | 2.67% | 2.66% | Upgrade
|
| Effective Tax Rate | 17.68% | 18.20% | 17.62% | 24.93% | 17.66% | 18.01% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.